127 related articles for article (PubMed ID: 31902977)
21. Nudix hydrolases degrade protein-conjugated ADP-ribose.
Daniels CM; Thirawatananond P; Ong SE; Gabelli SB; Leung AK
Sci Rep; 2015 Dec; 5():18271. PubMed ID: 26669448
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial NUDIX hydrolases: A metabolic link between NAD catabolism, GTP and mitochondrial dynamics.
Long A; Klimova N; Kristian T
Neurochem Int; 2017 Oct; 109():193-201. PubMed ID: 28302504
[TBL] [Abstract][Full Text] [Related]
23. Who Put the "A" in ATP? Generation of ATP from ADP-Ribose in the Nucleus for Hormone-Dependent Gene Regulation.
Ryu KW; Kraus WL
Mol Cell; 2016 Aug; 63(3):349-51. PubMed ID: 27494555
[TBL] [Abstract][Full Text] [Related]
24. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
[TBL] [Abstract][Full Text] [Related]
26. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
27. Alr2954 of Anabaena sp. PCC 7120 with ADP-ribose pyrophosphatase activity bestows abiotic stress tolerance in Escherichia coli.
Singh PK; Shrivastava AK; Singh S; Rai R; Chatterjee A; Rai LC
Funct Integr Genomics; 2017 Jan; 17(1):39-52. PubMed ID: 27778111
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Biological Investigation and Docking Study of Novel Chromen Derivatives as Anti-Cancer Agents.
Dube PN; Sakle NS; Dhawale SA; More SA; Mokale SN
Anticancer Agents Med Chem; 2019; 19(9):1150-1160. PubMed ID: 30848213
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
Chadha N; Jaggi AS; Silakari O
Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
[TBL] [Abstract][Full Text] [Related]
30. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.
Goebel DJ; Winkler BS
J Neurochem; 2006 Sep; 98(6):1732-45. PubMed ID: 16903875
[TBL] [Abstract][Full Text] [Related]
31. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
32. Structure-Based Virtual Screening of High-Affinity ATP-Competitive Inhibitors Against Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: A Novel Therapeutic Target for Breast Cancer.
Sarma H; Mattaparthi VSK
Interdiscip Sci; 2019 Sep; 11(3):527-541. PubMed ID: 30066129
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
34. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
35. Substrate specificity characterization for eight putative nudix hydrolases. Evaluation of criteria for substrate identification within the Nudix family.
Nguyen VN; Park A; Xu A; Srouji JR; Brenner SE; Kirsch JF
Proteins; 2016 Dec; 84(12):1810-1822. PubMed ID: 27618147
[TBL] [Abstract][Full Text] [Related]
36. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B
Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115
[TBL] [Abstract][Full Text] [Related]
37. Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.
De Donato M; Righino B; Filippetti F; Battaglia A; Petrillo M; Pirolli D; Scambia G; De Rosa MC; Gallo D
Sci Rep; 2018 Oct; 8(1):16047. PubMed ID: 30375481
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Novel Human Epidermal Growth Factor Receptor-2 Inhibitors by Structure-based Virtual Screening.
Shi Z; Yu T; Sun R; Wang S; Chen XQ; Cheng LJ; Liu R
Pharmacogn Mag; 2016; 12(46):139-44. PubMed ID: 27076751
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
40. [Mechanistic insight into hydrolysis of oxidized nucleotide diphosphates by human NUDT5].
Arimori T; Yamagata Y
Fukuoka Igaku Zasshi; 2011 Nov; 102(11):303-12. PubMed ID: 22351996
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
